Contipro a.s, Dolní Dobrouč 401, 561 02, Dolnί Dobrouč, Czech Republic.
Contipro a.s, Dolní Dobrouč 401, 561 02, Dolnί Dobrouč, Czech Republic.
Carbohydr Polym. 2021 May 1;259:117697. doi: 10.1016/j.carbpol.2021.117697. Epub 2021 Jan 26.
Ophthalmic disorders are amid the most common pathologies worldwide. In this regard, hyaluronan (HA) has gained widespread use in eye surgeries and treatment of eye diseases. HA-based materials are well tolerated and show excellent biocompatibility. Therefore, HA is a sought-after component of ophthalmic formulations. However, several parameters have to be adjusted to reach an optimal performance and effectiveness. The complexity of HA properties represents a major challenge for biological and structural characterization. This review covers fundamental aspects and recent developments in HA ophthalmic research. Biological mechanisms underlying the health benefits of HA and their potential therapeutic applications are elaborated. Furthermore, current pharmacokinetic and safety studies are discussed. Noticeably, the benefits of chemical modification and processed HA forms are described to broaden the applications of this unique polysaccharide. The current research challenges and prospects are also outlined and discussed.
眼科疾病是全球最常见的疾病之一。在这方面,透明质酸(HA)已广泛应用于眼科手术和眼病治疗。基于 HA 的材料具有良好的耐受性和出色的生物相容性。因此,HA 是眼科制剂中备受追捧的成分。然而,为了达到最佳性能和效果,需要调整几个参数。HA 性质的复杂性是生物和结构特性分析的主要挑战。本综述涵盖了 HA 在眼科研究中的基础方面和最新进展。详细阐述了 HA 对健康的有益作用的生物学机制及其潜在的治疗应用。此外,还讨论了当前的药代动力学和安全性研究。值得注意的是,描述了化学修饰和加工后的 HA 形式的益处,以拓宽这种独特多糖的应用。还概述和讨论了当前的研究挑战和前景。